JTC Employer Solutions Trustee’s Adaptive Biotechnologies ADPT Stock Holding History

JTC Employer Solutions Trustee’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$121K	Hold	5,633	–	–	0.01%	194
2026 Q1	$78K	Sell	5,633 -6,102	-52%	-$97.2K	0.01%	220
2025 Q4	$191K	Hold	11,735	–	–	0.01%	158
2025 Q3	$176K	Buy	11,735 +6,626	+130%	+$80.7K	0.02%	161
2025 Q2	$59K	Hold	5,109	–	–	0.01%	224
2025 Q1	$38K	Hold	5,109	–	–	﹤0.01%	250
2024 Q4	$31K	Hold	5,109	–	–	﹤0.01%	263
2024 Q3	$26K	Buy	+5,109	New	+$22.3K	﹤0.01%	270

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JTC Employer Solutions Trustee's ADPT Position: Q2 2026 in Review

JTC Employer Solutions Trustee held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 5,633 shares worth $121K. The position accounts for 0.01% of the portfolio, ranked #194.

JTC Employer Solutions Trustee first reported a position in ADPT in Q3 2024 and has held it in 8 quarters since. The position peaked at $191K in Q4 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

JTC Employer Solutions Trustee held 5,633 shares of Adaptive Biotechnologies worth $121K as of Q2 2026.
JTC Employer Solutions Trustee left its Adaptive Biotechnologies share count unchanged in Q2 2026.
Adaptive Biotechnologies made up 0.01% of JTC Employer Solutions Trustee's portfolio in Q2 2026, its #194 holding.
JTC Employer Solutions Trustee first reported a position in Adaptive Biotechnologies in Q3 2024 and has held it in 8 quarters since.
JTC Employer Solutions Trustee's Adaptive Biotechnologies position peaked at $191K in Q4 2025.
300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on JTC Employer Solutions Trustee's 13F filing for Q2 2026, filed 31 Jul 2026.